Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics

This article was originally published in The Tan Sheet

Executive Summary

Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.
Advertisement

Related Content

J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon
Changes For Spending Account OTC Reimbursement Will Hit Consumers
FDA Warns In Recall Guidance Agency Has Arsenal Of Enforcement Options
FTC Raises Claim Substantiation Bar For Dietary Supplements In Settlements
FDA To Toughen OTC Oversight, Seek New Authority In Wake Of J&J Recalls
Omega-3 Probe Underscores FTC Standard For Claims Substantiation
McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs
McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs
Rx-to-OTC Switch Interest Explodes Following Deal Activity - Experts
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions

Topics

Advertisement
UsernamePublicRestriction

Register

PS104802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel